MONDAY, Nov. 9, 2020 (American Heart Association News) — Physical activity may reduce the risk of death from cardiovascular disease among American Indians, according to new research that
THURSDAY, Oct. 29, 2020 — An Eli Lilly-developed COVID-19 antibody drug that didn’t help hospitalized patients might still prove effective in treating people with mild or moderate infections,
Cedrión, a company supported by the Universidad Carlos III de Madrid (UC3M), has designed a disinfection system that could neutralize COVID-19 in just over 10 minutes. The system
When it comes to taking bets on what’s next in healthcare, investors are often the ones calling the shots. Hemant Taneja, managing director of General Catalyst, has sat
A study from the University of Pittsburgh School of Medicine and Cedars-Sinai addresses a mystery first raised in March: Why do some people with COVID-19 develop severe inflammation?
WEDNESDAY, Sept. 23, 2020 — If you’re unfortunate enough to be admitted to the hospital with COVID-19, a common blood marker may predict how severe your illness might
An international, multi-billion-dollar race is underway to develop a COVID-19 vaccine, and progress is moving at record speed, but with nationalistic, competitive undertones. If and when an effective
Parents and children surveyed about the COVID-19 pandemic in late April and early May of 2020—when most schools and day care providers closed their doors—said they had become
While about a quarter of physicians and researchers working in advanced heart failure (HF) and transplant cardiology are women, representation of women leading HF research remains limited, according
If you’ve upped your alcohol consumption in lockdown, you’re not the only one. But have you thought about how you’re going to get your drinking levels back down
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
